DiagnosisIf you have signs or symptoms of acute myelogenous leukemia, your doctor may recommend that you undergo diagnostic tests, including: Show
If your doctor suspects leukemia, you may be referred to a doctor who specializes in blood cancer (hematologist or medical oncologist). Determining your AML subtypeIf your doctor determines that you have AML, you may need further tests to determine the extent of the cancer and classify it into a more specific AML subtype. Your AML subtype is based on how your cells appear when examined under a microscope. Special laboratory testing also may be used to identify the specific characteristics of your cells. Your AML subtype helps determine which treatments may be best for you. Doctors are studying how different types of cancer treatment affect people with different AML subtypes. Determining your prognosisYour doctor uses your AML subtype and other information to determine your prognosis and decide on your treatment options. Other types of cancer use numerical stages to indicate your prognosis and whether your cancer has spread, but there are no stages of acute myelogenous leukemia. Instead, the seriousness of your condition is determined by:
TreatmentTreatment of acute myelogenous leukemia depends on several factors, including the subtype of the disease, your age, your overall health and your preferences. In general, treatment falls into two phases:
Therapies used in these phases include:
Clinical trialsExplore Mayo Clinic studies testing new treatments, interventions and tests as a means to prevent, detect, treat or manage this condition. Alternative medicineNo alternative treatments have been found helpful in treating acute myelogenous leukemia. But some complementary and alternative treatments may relieve the symptoms you experience due to cancer or cancer treatment. Alternative treatments that may help relieve symptoms include:
Coping and supportAcute myelogenous leukemia is an aggressive form of cancer that typically demands quick decision-making. That leaves people with a new diagnosis faced with important decisions about a disease they may not yet understand. Here are some tips for coping:
Preparing for your appointmentMake an appointment with your family doctor if you have signs and symptoms that worry you. If your doctor suspects you may have leukemia, you'll likely be referred to a doctor who specializes in blood cell diseases (hematologist). Because appointments can be brief, and because there's often a lot of information to discuss, it's a good idea to be prepared. Here's some information to help you get ready and know what to expect from your doctor. What you can do
Your time with your doctor is limited, so preparing a list of questions can help you make the most of your time together. List your questions from most important to least important in case time runs out. For acute myelogenous leukemia, some basic questions to ask include:
In addition to the questions that you've prepared to ask your doctor, don't hesitate to ask other questions. What to expect from your doctorYour doctor is likely to ask you a number of questions. Being ready to answer them may allow time later to cover other points you want to address. Your doctor may ask:
What you can do in the meantimeAvoid activities that worsen your signs and symptoms. For instance, try to take it easy if you're feeling fatigued. Sept. 21, 2022 Which assessment data should the nurse expect to observe in the client with anemia?In an initial evaluation, the hemoglobin, hematocrit, reticulocyte count, and RBC indices, particularly the mean corpuscular volume and red cell distribution width are taken to assess for the presence of anemia.
Which laboratory result is consistent with a diagnosis of thrombocytopenia?A complete blood count (CBC) measures the levels of red blood cells, white blood cells, and platelets in your blood. For this test, a small amount of blood is drawn from a blood vessel, usually in your arm. If you have thrombocytopenia, the results of this test will show that your platelet count is low.
Which diagnostic finding is a hallmark of chronic myelogenous leukemia CML )?The presence of BCR/ABL rearrangement is the hallmark of chronic myelogenous leukaemia (CML), although this rearrangement has also been described in other diseases. It is considered diagnostic when present in a patient with clinical manifestations of CML [15].
Which laboratory test would provide information about the number of megakaryocytes?Bone Marrow Examination
Bone marrow aspiration and biopsy in patients with immune thrombocytopenia (ITP) demonstrates a normal-to-increased number of megakaryocytes in the absence of other significant abnormalities.
|